SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rocketman who wrote (4435)3/20/1998 4:51:00 PM
From: Biomaven  Read Replies (3) of 9719
 
Rman asked V1:
<<MOGN has a nice runup going for it. Any idea what it is based on? You still hot on holding it long?>>

Yes, yes, yes is my opinion. I just added to my (already too large) holding in the dip before the recent two-day run-up.

Several things happening:
1) Recent approval for Salagen for Sjogren's syndrome. The stock reacted nicely, and then gave up its gains, probably because of ...

2) Tired old holder dumped a big block of stock recently, now apparently absorbed.

3) Some very nice looking MGI-114 abstracts at the upcoming Cancer conference. (V1 will grumble that nude mice ain't people, but nobody wants to listen to him on this issue). The abstracts are posted on the MOGN thread. (Like there's even some complete responses when combined with another existing drug in a nasty human colon cancer xenograft line that existing combinations can barely slow down).

4) Speculation that a European partner for MGI-114 is in the wings, and that an advance to Phase II is close.

I'll probably lighten up a little if the run continues, but that's because I'm so overweighted with it already.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext